For: | Abdulla M, Al Ghareeb AM, Husain HAHY, Mohammed N, Al Qamish J. Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C. World J Clin Cases 2022; 10(34): 12566-12577 [PMID: PMC9791528 DOI: 10.12998/wjcc.v10.i34.12566] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i34/12566.htm |
Number | Citing Articles |
1 |
Khalid M. Al-Naamani, Heba Omar, Said A. Al Busafi, Halima H. Al Shuaili, Zakariya Al-Naamani, Murtadha Al-Khabori, Elias A. Said, Abdullah H. AlKalbani, B. R. Kamath, Bashar Emad, Shahina Daar, Lolo Alhajri, Alya AlKalbani, Zainab AlFarsi, Haifa Alzuhaibi. Real-World Experience, Effectiveness, and Safety of Direct-Acting Antivirals for the Treatment of Hepatitis C in Oman: A Cross-Sectional, Multicenter Study. Journal of Clinical Medicine 2024; 13(23): 7411 doi: 10.3390/jcm13237411
|
2 |
Lynette Goh, Winita Hardikar. Hepatitis C in Children—An Asia–Pacific Concise Perspective. Pathogens 2024; 13(10): 860 doi: 10.3390/pathogens13100860
|
3 |
Piotr Rzymski, Aliyu Tijani Jibril, Laila Rahmah, Sunny O. Abarikwu, Fareeda Hashem, Abdullah Al Lawati, Fiona McGowan Martha Morrison, Leander Penaso Marquez, Kawthar Mohamed, Amjad Khan, Saima Mushtaq, Kseniia Minakova, Barbara Poniedziałek, Dorota Zarębska‐Michaluk, Robert Flisiak. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches. Journal of Medical Virology 2024; 96(9) doi: 10.1002/jmv.29900
|